Crossmark

A Python library for probabilistic analysis of single-cell omics data

Crossref DOI link: https://doi.org/10.1038/s41587-021-01206-w

Published Online: 2022-02-07

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gayoso, Adam https://orcid.org/0000-0001-9537-0845
Lopez, Romain https://orcid.org/0000-0003-0495-738X
Xing, Galen

Boyeau, Pierre

Valiollah Pour Amiri, Valeh https://orcid.org/0000-0002-2008-5297
Hong, Justin https://orcid.org/0000-0003-2115-9101
Wu, Katherine

Jayasuriya, Michael

Mehlman, Edouard

Langevin, Maxime

Liu, Yining

Samaran, Jules

Misrachi, Gabriel

Nazaret, Achille

Clivio, Oscar

Xu, Chenling https://orcid.org/0000-0001-9610-7627
Ashuach, Tal

Gabitto, Mariano

Lotfollahi, Mohammad https://orcid.org/0000-0001-6858-7985
Svensson, Valentine

da Veiga Beltrame, Eduardo

Kleshchevnikov, Vitalii

Talavera-López, Carlos

Pachter, Lior https://orcid.org/0000-0002-9164-6231
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Streets, Aaron https://orcid.org/0000-0002-3909-8389
Jordan, Michael I. https://orcid.org/0000-0001-8935-817X
Regier, Jeffrey https://orcid.org/0000-0002-1472-5235
Yosef, Nir https://orcid.org/0000-0001-9004-1225
License Information

Text and Data Mining valid from 2022-02-01

Version of Record valid from 2022-02-01
More Information

Article History

First Online: 7 February 2022

Competing interests

: V.S. is a full-time employee of Serqet Therapeutics and has ownership interest in Serqet Therapeutics. F.J.T. reports consulting fees from Roche Diagnostics GmbH and Cellarity Inc., and ownership interest in Cellarity, Inc. N.Y. is an advisor to and/or has equity in Cellarity, Celsius Therapeutics and Rheos Medicines. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below